Full-service contract research organisation (CRO) LINK Medical has entered a collaboration agreement with Viedoc for a new partnership programme to enhance clinical trial efficiency.
Established by Viedoc, the programme is intended to boost the efficiency of the trials for LINK Medical and its clients.
It also facilitates an uninterrupted interchange of experience, needs, and ideas, and the testing of new features.
LINK Medical CEO Ola Gudmundsen said: “We have used Viedoc as our EDC system for almost two decades and built more than 400 studies with it.
“The new partnership agreement ensures that we can continue to build on the extensive experience with Viedoc and to deliver advanced and user-friendly EDC solutions to our clients well into the future.
“In addition, the growing suite of eClinical solutions from Viedoc provides us with the ideal tools to deliver more complex and efficient trials such as decentralised trials to our clients.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
LINK Medical is currently an established Master Viedoc user with possessing expertise in all Viedoc features.
The CRO previously had a three-year collaboration agreement in place with Viedoc. With the latest development, the deal has been renewed for an additional period of three years.
In accordance with the new contract, LINK Medical will be able to leverage the existing benefits of the system and guarantee its quick development in line with customer requirements.
Based in Sweden, Viedoc creates software for the life science sector to support key pharmaceutical, biotech and medical device firms, as well as research institutions globally by expediting clinical trials on all levels.